These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10170601)

  • 1. A new era in the European marketplace.
    Wagner M
    Mod Healthc; 1990 Oct; 20(39):26-7, 30-3. PubMed ID: 10170601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 3. U.S. hospital chains retreat from Europe.
    Nemes J
    Mod Healthc; 1991 Sep; 21(36):39-40. PubMed ID: 10170800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray marketing of pharmaceuticals.
    Chaudhry PE; Walsh MG
    J Health Care Mark; 1995; 15(3):18-22. PubMed ID: 10172516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global markets await. Upcoming economic transition may provide the opening U.S. healthcare merchants need.
    Dine DD
    Mod Healthc; 1989 Jun; 19(23):20-1, 24, 26-7. PubMed ID: 10318255
    [No Abstract]   [Full Text] [Related]  

  • 6. E-commerce for healthcare supply procurement.
    Arbietman D; Lirov E; Lirov R; Lirov Y
    J Healthc Inf Manag; 2001; 15(1):61-72. PubMed ID: 11338910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social security reform in Central and Eastern Europe: variations on a Latin American theme.
    Kritzer BE
    Soc Secur Bull; 2001-2002; 64(4):16-32. PubMed ID: 12822190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts on industry of Europe's emerging chemicals policy REACh.
    Angerer G; Nordbeck R; Sartorius C
    J Environ Manage; 2008 Mar; 86(4):636-47. PubMed ID: 17321032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future European health care: cost containment, health care reform and scientific progress in drug research.
    Emilien G
    Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triple-A supply chain.
    Lee HL
    Harv Bus Rev; 2004 Oct; 82(10):102-12, 157. PubMed ID: 15559579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New product opportunities with DRGs.
    Anthony FH
    Hosp Pharm; 1985 Jan; 20(1):10-1. PubMed ID: 10310980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of floriculture in Europe.
    Van Huylenbroeck J
    Methods Mol Biol; 2010; 589():365-76. PubMed ID: 20099115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How managers can prepare their companies for the new Europe. 1992: moves Americans must make.
    Magee JF
    Harv Bus Rev; 1989; 67(3):78-84. PubMed ID: 10318234
    [No Abstract]   [Full Text] [Related]  

  • 15. Ambulatory care centers. An evolving market provides supply opportunities.
    Henderson JA
    Health Ind Today; 1988 Mar; 51(3):25-7. PubMed ID: 10286670
    [No Abstract]   [Full Text] [Related]  

  • 16. 1989 sales forecasts. Global economy hits home.
    Albertson D
    Health Ind Today; 1989 Jan; 52(1):18-20. PubMed ID: 10291406
    [No Abstract]   [Full Text] [Related]  

  • 17. European legislation of biomedical technology.
    Mambretti C
    Ann Ist Super Sanita; 1995; 31(1):109-12. PubMed ID: 8546358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supply chain challenges. building relationships.
    Beth S; Burt DN; Copacino W; Gopal C; Lee HL; Lynch RP; Morris S
    Harv Bus Rev; 2003 Jul; 81(7):64-73, 117. PubMed ID: 12858712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraterritorial reach of the FCPA: recommendations for U.S. medical device companies with activities in Europe.
    Vollebregt E
    Food Drug Law J; 2010; 65(2):347-65, iii. PubMed ID: 24475545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organizing evaluation of chemical substances in EEC countries and in Poland prior to their admission to trade turnover].
    Indulski JA; Rolecki R
    Med Pr; 1993; 44(3):261-76. PubMed ID: 8231798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.